Linda Carol Laux MD
Child Neurology
Assistant Professor in Pediatrics, Northwestern University Medical School
Join to View Full Profile
225 E Chicago Ave#29Chicago, IL 60611
Phone+1 312-227-3540
Fax+1 312-227-6940
Dr. Laux is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Phoenix Children's HospitalFellowship, Child Neurology, 1994 - 1997
University of Arizona College of Medicine-TucsonResidency, Pediatrics, 1990 - 1993
Saint Louis University School of MedicineClass of 1990
Certifications & Licensure
IL State Medical License 2000 - 2026
AZ State Medical License 1994 - 2010
American Board of Psychiatry and Neurology Neurology with Special Qualification in Child Neurology- American Board of Psychiatry and Neurology Clinical Neurophysiology
- American Board of Psychiatry and Neurology Epilepsy
Clinical Trials
- Verapamil as Therapy for Children and Young Adults With Dravet Syndrome Start of enrollment: 2012 Apr 01
Publications & Presentations
PubMed
- It's About Time! Timing in Epilepsy Evaluation and Treatment.Heather Ravvin McKee, Jorge Vidaurre, Dave Clarke, Janelle Wagner, Jeffrey W Britton
Epilepsy Currents. 2024-04-01 - 6 citationsSevere communication delays are independent of seizure burden and persist despite contemporary treatments in SCN1A+ Dravet syndrome: Insights from the ENVISION natural...M Scott Perry, Ingrid E Scheffer, Joseph Sullivan, Andreas Brunklaus, Susana Boronat
Epilepsia. 2024-02-01 - 23 citationsFenfluramine in the treatment of Dravet syndrome: Results of a third randomized, placebo-controlled clinical trial.Joseph Sullivan, Lieven Lagae, J Helen Cross, Orrin Devinsky, Renzo Guerrini
Epilepsia. 2023-10-01
Press Mentions
The Design and Impact of a Hospital-Based Neurodiagnostic Training Program in Electroencephalography and Polysomnography TechnologyAugust 8th, 2024- Antisense Oligonucleotide Shows Potential in Dravet SyndromeDecember 9th, 2022
- Stoke Therapeutics : Presents Data from a Combined Interim Analysis of the Phase 1/2a - Form 8-KDecember 2nd, 2022
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
